Vdyne, Inc.
Clinical trials sponsored by Vdyne, Inc., explained in plain language.
-
New heart valve device offers hope for patients with leaky tricuspid valve
Disease control Recruiting nowThis study tests a new device called the VDyne System to replace the tricuspid valve in people with severe tricuspid regurgitation (a leaky heart valve). The goal is to see if the device is safe and can improve symptoms, exercise ability, and quality of life. About 30 adults with…
Phase: NA • Sponsor: VDyne, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:02 UTC
-
New heart valve replacement could spare patients from major surgery
Disease control Recruiting nowThis study tests a new device called the VDyne System, which is placed through a tube in a blood vessel to replace the tricuspid valve in the heart. It is for people with severe tricuspid regurgitation, a condition where the valve does not close properly, causing blood to leak ba…
Phase: NA • Sponsor: VDyne, Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC